It can take years for people living with chronic fatigue syndrome to receive a formal diagnosis, and they are a favored few. Experts suggest up to 91 percent of people in the US remain undiagnosed, living without medical support for a condition that robs them of energy, brain-power, and a care-free life.
But those statistics could in time improve, if a newly developed diagnostic test stands up to scrutiny.
A team of scientists led by the University of Oxford has just published their preliminary results of a blood cell-based test that can distinguish between unaffected individuals and those with chronic fatigue syndrome (also known as myalgic encephalomyelitis or ME/CFS) with 91 percent accuracy.
